Showing 1 - 1 results of 1 for search 'Yingkui Liang', query time: 0.01s Refine Results
  1. 1
    Safety, pharmacokinetics, and dosimetry of 177Lu-AB-3PRGD2 in patients with advanced integrin αvβ3-positive tumors: A first-in-human study

    Safety, pharmacokinetics, and dosimetry of 177Lu-AB-3PRGD2 in patients with advanced integrin αvβ3-positive tumors: A first-in-human study by Huimin Sui, Feng Guo, Hongfei Liu, Rongxi Wang, Linlin Li, Jiarou Wang, Chenhao Jia, Jialin Xiang, Yingkui Liang, Xiaohong Chen, Zhaohui Zhu, Fan Wang

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: